Clinical Trial Update: Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease [NA]

View source ↗

Summary

A clinical trial evaluating rosiglitazone extended-release tablets as an adjunctive therapy for mild-to-moderate Alzheimer's disease has completed, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Rosiglitazone Extended Release Tablets (rosiglitazone)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Alzheimer's Disease | NA | Status: COMPLETED | Results posted: 2017-11-28